Cover Image

Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma

Lemeng Zhang, Yongzhong Luo, Tianli Cheng, Jianhua Chen, Hua Yang, Xiaoping Wen, Zhou Jiang, Haitao Li, Changqie Pan Thoracic Medicine Department 1, Hunan Cancer Hospital, Changsha, Hunan Province, 410013, People's Republic of ChinaCorrespondence: Yongzhong Luo Tel/Fax +86-731-89762220Email luo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhang L (Author), Luo Y (Author), Cheng T (Author), Chen J (Author), Yang H (Author), Wen X (Author), Jiang Z (Author), Li H (Author), Pan C (Author)
Format:	Book
Published:	Dove Medical Press, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
by: Yanhua Zuo, et al.
Published: (2023)

Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes
by: Guo-Sheng Li, et al.
Published: (2022)

Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
by: Chen Gao, et al.
Published: (2022)

Biomarkers Associated with Immune Checkpoint, N6-Methyladenosine, and Ferroptosis in Patients with Restenosis
by: Tong X, et al.
Published: (2023)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
by: Xiong Tian, et al.
Published: (2022)

A Four-Gene Prognostic Signature Based on the TEAD4 Differential Expression Predicts Overall Survival and Immune Microenvironment Estimation in Lung Adenocarcinoma
by: Xiaoxia Gong, et al.
Published: (2022)

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
by: Yao Y, et al.
Published: (2021)

Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
by: Jian-Gang Zhao, et al.
Published: (2023)

The role of RNA N6-methyladenosine methyltransferase in cancers
by: Jiali Huang, et al.
Published: (2021)

New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
by: Wenli Cheng, et al.
Published: (2022)

Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma
by: Yu Ma, et al.
Published: (2024)

An EV-Associated Gene Signature Correlates with Hypoxic Microenvironment and Predicts Recurrence in Lung Adenocarcinoma
by: Bangrong Cao, et al.
Published: (2019)

Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity
by: Jiang S, et al.
Published: (2023)

Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics
by: Xiang Y, et al.
Published: (2024)

Association of N6-methyladenosine readers' genes variation and expression level with pulmonary tuberculosis
by: Hong-Miao Li, et al.
Published: (2022)

Construction and experimental validation of an acetylation-related gene signature to evaluate the recurrence and immunotherapeutic response in early-stage lung adenocarcinoma
by: Haiqiang Wang, et al.
Published: (2022)

Prognostic analysis of patients with gastric cancer based on N6-methyladenosine modification patterns and tumor microenvironment characterization
by: Miaomiao Huo, et al.
Published: (2024)

YTHDF3 promotes melanoma metastasis by reading N6‐methyladenosine
by: Ivan Yu Cheng, et al.
Published: (2022)

Exploring Unique Extracellular Vesicles Associated Signatures: Prognostic Insights, Immune Microenvironment Dynamics, and Therapeutic Responses in Pancreatic Adenocarcinoma
by: Kai Nan, et al.
Published: (2024)

Prognostic value of eight immune gene signatures in pancreatic cancer patients
by: Wenting Wang, et al.
Published: (2021)

The crosstalk between N6‐methyladenosine readers and neuroblastoma
by: Liping Chen, et al.
Published: (2024)

RNA N6-methyladenosine methylation and skin diseases
by: Yaqin Yu, et al.
Published: (2023)

Prognostic characteristics of T-cell mediated cell killing-related genes in lung adenocarcinoma
by: Lei Bi, et al.
Published: (2023)

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
by: Jia-Hao Zheng, et al.
Published: (2022)

Development of somatic mutation signatures for risk stratification and prognosis in lung and colorectal adenocarcinomas
by: Mark Menor, et al.
Published: (2019)

Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma
by: Tingting Li, et al.
Published: (2022)

N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases
by: Yan Teng, et al.
Published: (2023)

Novel insights into the interaction between N6-methyladenosine modification and circular RNA
by: Tao Xu, et al.
Published: (2022)

Development of a multi-gene-based immune prognostic signature in ovarian Cancer
by: Tiefeng Cao, et al.
Published: (2021)

Function and prognostic value of basement membrane -related genes in lung adenocarcinoma
by: Yurong Zhang, et al.
Published: (2023)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
by: Mengzhe Zhang, et al.
Published: (2023)

Molecular Signatures of -Mutated Lung Adenocarcinoma: Analysis of Concomitant , , , and PD-L1 Status
by: Jim Hsu, et al.
Published: (2022)

The role of N-methyladenosine modification in acute and chronic kidney diseases
by: Saiqi Qi, et al.
Published: (2023)

Dual effects of N6-methyladenosine on cancer progression and immunotherapy
by: Hui Li, et al.
Published: (2021)

TPD52L2 Is a Prognostic Biomarker and Correlated With Immune Infiltration in Lung Adenocarcinoma
by: Anyuan Zhong, et al.
Published: (2021)

Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma
by: Yibo Ma, et al.
Published: (2023)

Identification of Neutrophil Extracellular Trap-Related Gene Expression Signatures in Ischemia Reperfusion Injury During Lung Transplantation: A Transcriptome Analysis and Clinical Validation
by: Gao J, et al.
Published: (2024)

Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma
by: Ping S, et al.
Published: (2021)

Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment
by: Jiao Zhou, et al.
Published: (2023)

A Linear Regression Predictor for Identifying N6-Methyladenosine Sites Using Frequent Gapped K-mer Pattern
by: Y.Y. Zhuang, et al.
Published: (2019)